• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Artificial Heart Market Trends

    ID: MRFR/HC/6513-HCR
    90 Pages
    Rahul Gotadki
    October 2025

    Artificial Heart Market Research Report Information by Type (Heart-Lung Machine, Mechanical Heart, Total Artificial Hearts, Ventricular Assist Devices (VADs)), End User (Hospitals & Clinics, Specialty Centers) and Region (Americas, Europe, Asia-Pacific, Middle East Africa) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Artificial Heart Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Trends

    Key Emerging Trends in the Artificial Heart Market

    The artificial heart market is experiencing a surge in technological advancements, with ongoing research and development focusing on enhancing the efficiency and durability of artificial heart devices. Miniaturization, improved materials, and sophisticated control mechanisms are contributing to more reliable and effective artificial heart solutions. It is technological innovation that has opened the market for artificial heart; it forms a vital factor of this market. This research and development targets at improving the resistance capacity, effectiveness, and biocompatibility of artificial hearts. The fusion of substances as titanium, and advanced pumping technologies contribute to the emergence of even more advanced artificial heart designs. The market dynamics are profoundly affected by the growing cardiovascular disease and particularly, heart failure incidences. The growing number of aging population and the heart related factors spilling over from life style diseases, the need for artificial hearts as a therapeutic alternative is quickly moving. The rising target population drives market growth. The feature with regard to the competitive landscape of this market is that a few leading companies are engaged in investing significant amount on research and development to get an advantage. Collaborations, mergers and acquisitions are the most widely used means to increase market presence of the companies and enrich their product lines which are helping in giving thrust to overall dynamism of artificial heart market. Geographic differences in the quality of infrastructure related to healthcare, patient populations and surrounding regulatory environment also impact on existing market dynamics. Better medical facilities in the developed regions and poor accessibility or awareness towards HIV AIDS problems, as observed in developing countries, can be factors that hinder adoption comparatively with less rapidly than developed nations. Artificial hearths combined with digital health technologies in major developments that change the market dynamics rapidly. Telemonitoring, data analytics solutions for patient care based on connectivity solutions are gradually improving patients’ lifestyle and provide valuable insight to the health professionals which in turn is pushing the field of telehealth. The trends within the market indicate a move in consumer orientation. Customization of artificial heart solutions according to needs and preferences of individual patients is becoming a more important issue in this topic. This patient-centered approach does more than just improve the satisfaction of patients, but also becomes a factor that brings better clinical results. The integration of artificial intelligence in cardiac care, including artificial hearts, is a notable trend. AI algorithms are being used for real-time monitoring, predictive analysis, and personalized treatment plans. This integration enhances the efficiency of artificial heart devices and contributes to better patient outcomes.

    Market Summary

    The Global Artificial Heart Market is projected to grow from 5 USD Billion in 2024 to 7.47 USD Billion by 2032.

    Key Market Trends & Highlights

    Artificial Heart Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 3.71% from 2025 to 2032.
    • By 2035, the market valuation is anticipated to reach 7.47 USD Billion, reflecting a steady increase.
    • In 2024, the market is valued at 5 USD Billion, indicating a robust foundation for future growth.
    • Growing adoption of artificial hearts due to advancements in medical technology is a major market driver.

    Market Size & Forecast

    2024 Market Size 5 (USD Billion)
    2035 Market Size 7.47 (USD Billion)
    CAGR (2025-2035) 3.71%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    SynCardia Systems, CryoLife, LLC, ABIOMED, CARMAT, Abbott, Cleveland Heart Inc., Thoratec Corporation

    Market Trends

    Drivers- the high increase in market demand of the artificial heart is due to the highly increased cardiovascular disorder among the population along with the increase in the aging population suffering from final stage heart failure. People engaging themselves in smoking along with reimbursement policies so implemented drives up the artificial heart valve market rate and its market value. People developing a high risk of heart complications increase the market growth of artificial heart.

    Opportunities- medical device manufacturer is the lucrative opportunity that helps in driving up market growth. Some of the market drivers are an adaptation of new healthcare technology along with taking government initiatives to increase the opportunities of the market. Increased unavailability of favorable insurance policies widens up the opportunities for expanding the market growth of artificial heart.

    Challenges- prevalence of HVD globally and regionally and certain regulatory approvals is the challenging factor towards the market growth.

    Cumulative growth- the presence of high market value of high USD and high CAGR projects at a high rate covering large market share.

    Restraints- strict rules so imposed by the government and the regulatory scenario so imposed as per the FDA policies are the factors that act as a restraining factor affecting the growth of the market. High costs of artificial heart valves along with the high treatment facilities and the regulations so imposed spoils up the market growth.

    The ongoing advancements in biocompatible materials and miniaturization technologies are poised to enhance the efficacy and accessibility of artificial hearts, potentially transforming cardiac care for patients worldwide.

    U.S. National Institutes of Health

    Artificial Heart Market Market Drivers

    Rising Prevalence of Cardiovascular Diseases

    The increasing incidence of cardiovascular diseases globally is a primary driver for the Global Artificial Heart Market Industry. As heart-related ailments continue to escalate, the demand for advanced cardiac solutions, including artificial hearts, is likely to rise. In 2024, the market is projected to reach 5 USD Billion, reflecting the urgent need for innovative treatments. This trend is expected to persist as the World Health Organization indicates that cardiovascular diseases remain the leading cause of death worldwide. Consequently, healthcare systems are compelled to invest in artificial heart technologies to address this growing health crisis.

    Market Segment Insights

    Artificial Heart Type Insights

    globally and regionally, the Artificial Heart Market has been classified into type and end-user. As per the type, the market is classified into the heart-lung machine and mechanical heart. The mechanical heart is further classified into total artificial hearts and ventricular assist devices.

     The mechanical heart part projects at a high CAGR value during the market forecast period which contributes much more to the rise in market demand. Based on the end-users, the heart valve market is divided into hospitals and clinics and some healthcare centers, and many more.

    Globally, the types of artificial heart valves expand to the region of America, Europe, Asia Pacific, some of the Middle East, and African regions. The Artificial Heart Market also expands to the regions of North America and some of Latin America areas where their region of North America includes the region of the United States and Canada.

    The market expanded to the European region and is divided into Western Europe and Eastern Europe. The Western European region includes some of the areas of Germany, France, Italian areas, the United Kingdom, Spain, and other regions of Western Europe.

     The market in the Asia Pacific market is divided into Japan, China, India, the South Korean region, Australia, and the rest of the Asia Pacific region.

    Artificial Heart Technology Insights

    due to advancement in technology advanced heart surgeries were used. It led to the invention of different types of artificial heart valves which functioned uniquely. Technology arouses awareness about the diagnosis facilities and the treatments. Technology led to the introduction of an innovative new artificial heart of low costs. The artificial heart cost and the cost of the artificial heart valve were not that huge.

    Get more detailed insights about Artificial Heart Market Research Report - Forecast till 2032

    Regional Insights

    Key Companies in the Artificial Heart Market market include

    Industry Developments

    • Q2 2024: SynCardia Announces FDA Approval for Next-Generation Total Artificial Heart SynCardia Systems received FDA approval for its next-generation Total Artificial Heart, designed to improve patient outcomes and device durability. The approval marks a significant milestone for the company and expands treatment options for patients with end-stage heart failure.
    • Q1 2024: Carmat Receives CE Mark Extension for Aeson Artificial Heart Carmat announced that it has received an extension of its CE Mark for the Aeson artificial heart, allowing continued commercial sales and use in European markets. The extension supports ongoing adoption of the device for patients with advanced heart failure.
    • Q2 2024: Carmat Resumes Aeson Artificial Heart Production After Manufacturing Suspension Carmat resumed production of its Aeson artificial heart following a temporary suspension due to quality control issues. The company implemented corrective actions and received regulatory clearance to restart manufacturing and distribution.
    • Q2 2024: SynCardia Systems Appoints New CEO to Drive Global Expansion SynCardia Systems announced the appointment of a new Chief Executive Officer, aiming to accelerate the company's global expansion and commercialization of its artificial heart technologies.
    • Q1 2024: Carmat Raises €30 Million to Fund Artificial Heart Commercialization Carmat completed a €30 million funding round to support the commercialization and scale-up of its Aeson artificial heart in Europe and other markets.
    • Q2 2024: Carmat Signs Distribution Agreement for Aeson Artificial Heart in Italy Carmat entered into a distribution agreement with a leading Italian medical device distributor to expand the availability of the Aeson artificial heart in Italy.
    • Q1 2024: FDA Grants Breakthrough Device Designation to BiVACOR Total Artificial Heart The FDA granted Breakthrough Device Designation to BiVACOR's Total Artificial Heart, recognizing its potential to provide more effective treatment for patients with severe heart failure.
    • Q2 2024: BiVACOR Announces First Human Implantation of Total Artificial Heart in U.S. Clinical Trial BiVACOR announced the successful first human implantation of its Total Artificial Heart as part of a U.S. clinical trial, marking a major milestone in the development of next-generation artificial heart technology.
    • Q2 2024: Carmat Opens New Manufacturing Facility for Aeson Artificial Heart Carmat inaugurated a new manufacturing facility dedicated to the production of its Aeson artificial heart, aiming to increase capacity and meet growing demand in Europe.
    • Q1 2024: SynCardia Systems Expands Distribution Network in Asia-Pacific SynCardia Systems announced the expansion of its distribution network in the Asia-Pacific region, partnering with local medical device companies to increase access to its Total Artificial Heart.
    • Q2 2024: Carmat Signs Strategic Partnership with Leading U.S. Cardiac Center Carmat entered into a strategic partnership with a major U.S. cardiac center to advance clinical research and adoption of the Aeson artificial heart in the United States.
    • Q1 2024: BiVACOR Secures $22 Million in Series B Funding to Advance Artificial Heart Development BiVACOR raised $22 million in Series B funding to accelerate the development and clinical testing of its Total Artificial Heart, supporting ongoing trials and regulatory submissions.

    Future Outlook

    Artificial Heart Market Future Outlook

    The Global Artificial Heart Market is projected to grow at a 3.71% CAGR from 2024 to 2032, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop innovative biocompatible materials for enhanced heart longevity.
    • Expand telemedicine solutions for remote monitoring of artificial heart patients.
    • Invest in partnerships with hospitals for integrated care pathways and patient education.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements and increased adoption of artificial heart technologies.

    Market Segmentation

    REPORT OVERVIEW

    Artificial Heart Market Industry Developments
    • {"Q2 2024: SynCardia Announces FDA Approval for Next-Generation Total Artificial Heart"=>[]}
    • {"Q1 2024: Carmat Receives CE Mark Extension for Aeson Artificial Heart"=>[]}
    • {"Q2 2024: Carmat Resumes Aeson Artificial Heart Production After Manufacturing Suspension"=>[]}
    • {"Q2 2024: SynCardia Systems Appoints New CEO to Drive Global Expansion"=>[]}
    • {"Q1 2024: Carmat Raises €30 Million to Fund Artificial Heart Commercialization"=>[]}
    • {"Q2 2024: Carmat Signs Distribution Agreement for Aeson Artificial Heart in Italy"=>[]}
    • {"Q1 2024: FDA Grants Breakthrough Device Designation to BiVACOR Total Artificial Heart"=>[]}
    • {"Q2 2024: BiVACOR Announces First Human Implantation of Total Artificial Heart in U.S. Clinical Trial"=>[]}
    • {"Q2 2024: Carmat Opens New Manufacturing Facility for Aeson Artificial Heart"=>[]}
    • {"Q1 2024: SynCardia Systems Expands Distribution Network in Asia-Pacific"=>[]}
    • {"Q2 2024: Carmat Signs Strategic Partnership with Leading U.S. Cardiac Center"=>[]}
    • {"Q1 2024: BiVACOR Secures $22 Million in Series B Funding to Advance Artificial Heart Development"=>[]}

    Report Scope

    Report Attribute/Metric Details
      Market Size   USD 5 Billion
      CAGR   14.30%
      Base Year 2023
      Forecast Period   2023-2032
      Historical Data   2020
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, and End user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   SynCardia Systems, LLC, BiVACOR Inc., CARMAT, Cleveland Heart, Inc., ABIOMED, CryoLife, Inc., Abbott, and Thoratec Corporation
      Key Market Opportunities   Medical device manufacturer
      Key Market Drivers ·  Adaptation of healthcare technology ·  Government initiatives to increase the healthcare quality ·  Availability of favorable insurance policies

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What was the valuation in 2030?

    The valuation was USD 4.98 billion.

    What is the predicted CAGR for the Artificial Heart Market for the forecast period (2022-2030)?

    The predicted CAGR would be 14.3%.

    What could slow down market growth?

    The high cost of the procedure and regulations regarding the process can slow down the growth.

    Which type to lead the market?

    The mechanical heart segment has the chance to record a higher CAGR.

    Which region would take charge of the artificial heart market?

    The Americas market would dominate the global field.

    1. Table of Contents:
    2. Chapter 1. Report Prologue
    3. Chapter 2. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Chapter 3. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    5. Chapter 4. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Detection Technique Trends & Assessment
    6. Chapter 5. Market Factor Analysis
      1. Porter’s Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    7. Chapter 6. Global Artificial Heart Market, by Type
      1. Introduction
      2. Heart-Lung Machine
    8. Market Estimates & Forecast, by Region, 2020-2027
    9. Market Estimates & Forecast, by Country, 2020-2027
      1. Mechanical Heart
    10. Market Estimates & Forecast, by Region, 2020-2027
      1. Total Artificial Hearts
    11. Market Estimates & Forecast, by Country, 2020-2027
      1. Ventricular Assist Devices (VADs)
    12. Market Estimates & Forecast, by Country, 2020-2027
    13. Chapter 7. Global Artificial Heart Market, by End User
      1. Introduction
      2. Hospitals & Clinics
    14. Market Estimates & Forecast, by Region, 2020-2027
    15. Market Estimates & Forecast, by Country, 2020-2027
      1. Specialty Centers
    16. Market Estimates & Forecast, by Region, 2020-2027
      1. Others
    17. Chapter 8. Global Artificial Heart Market, by Region
      1. Introduction
      2. Americas
        1. North America
        2. Latin America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia-Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia-Pacific
      5. Middle East & Africa
        1. Middle East
        2. Africa
    18. Chapter 9 Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
    19. Chapter 10. Company Profiles
      1. SynCardia Systems, LLC
        1. Company Overview
        2. Treatment Overview
        3. Financials Overview
        4. Key Developments
        5. SWOT Analysis
      2. BiVACOR Inc.
        1. Company Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      3. CARMAT
        1. Company Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      4. Cleveland Heart, Inc.
        1. Company Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      5. ABIOMED
        1. Company Overview
        2. Treatment Overview
        3. Financial overview
        4. Key Developments
        5. SWOT Analysis
      6. CryoLife, Inc.
        1. Company Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      7. Abbott
        1. Company Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      8. Thoratec Corporation
        1. Company Overview
        2. Treatment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
    20. Chapter 11 MRFR Conclusion
      1. Key Findings
        1. From CEO’s Viewpoint
        2. Unmet Needs of the Market
      2. Key Companies to Watch
      3. Predictions for the Artificial Heart Industry
    21. Chapter 12. Appendix
    22. List of Tables and Figures
      1. LIST OF TABLES
      2. Table 1 Global Artificial Heart Market Synopsis, 2020-2027
      3. Table 2 Global Artificial Heart Market Estimates and Forecast, 2020-2027 (USD Million)
      4. Table 3 Global Artificial Heart Market, by Region, 2020-2027 (USD Million)
      5. Table 4 Global Artificial Heart Market, by Type, 2020-2027 (USD Million)
      6. Table 5 Global Artificial Heart Market, by End-User, 2020-2027 (USD Million)
      7. Table 8 North America: Artificial Heart Market, by Type, 2020-2027 (USD Million)
      8. Table 9 North America: Artificial Heart Market, by End User, 2020-2027 (USD Million)
      9. Table 12 US: Artificial Heart Market, by Type, 2020-2027 (USD Million)
      10. Table 13 US: Artificial Heart Market, by End User, 2020-2027 (USD Million)
      11. Table 16 Canada: Artificial Heart Market, by Type, 2020-2027 (USD Million)
      12. Table 17 Canada: Artificial Heart Market, by End User, 2020-2027 (USD Million)
      13. Table 20 Latin America: Artificial Heart Market, by Type, 2020-2027 (USD Million)
      14. Table 21 Latin America: Artificial Heart Market, by End User, 2020– 2023 (USD Million)
      15. Table 24 Europe: Artificial Heart Market, by Type, 2020-2027 (USD Million)
      16. Table 25 Europe: Artificial Heart Market, by End User, 2020-2027 (USD Million)
      17. Table 28 Western Europe: Artificial Heart Market, by Type, 2020-2027 (USD Million)
      18. Table 29 Western Europe: Artificial Heart Market, by End User, 2020– 2023 (USD Million)
      19. Table 32 Eastern Europe: Artificial Heart Market, by Type, 2020-2027 (USD Million)
      20. Table 33 Eastern Europe: Artificial Heart Market, by End User, 2020– 2023 (USD Million)
      21. Table 36 Asia-Pacific: Artificial Heart Market, by Type, 2020-2027 (USD Million)
      22. Table 37 Asia-Pacific: Artificial Heart Market, by End User, 2020-2027 (USD Million)
      23. Table 40 Middle East & Africa: Artificial Heart Market, by Type, 2020-2027 (USD Million)
      24. Table 41 Middle East & Africa: Artificial Heart Market, by End User, 2020-2027 (USD Million) LIST OF FIGURES
      25. Figure 1 Research Process
      26. Figure 2 Segmentation for Global Artificial Heart Market
      27. Figure 3 Segmentation Market Dynamics for Global Artificial Heart Market
      28. Figure 4 Global Artificial Heart Market Share, by Type, 2020
      29. Figure 5 Global Artificial Heart Market Share, by End User, 2020
      30. Figure 7 Global Artificial Heart Market Share, by End User, 2020
      31. Figure 8 Global Artificial Heart Market Share, by Region, 2020
      32. Figure 9 North America: Artificial Heart Market Share, by Country, 2020
      33. Figure 10 Europe: Artificial Heart Market Share, by Country, 2020
      34. Figure 11 Asia-Pacific: Artificial Heart Market Share, by Country, 2020
      35. Figure 12 Middle East & Africa: Artificial Heart Market Share, by Country, 201
      36. Figure 13 Global Artificial Heart Market: Company Share Analysis, 2020 (%)
      37. Figure 14 SynCardia Systems, LLC: Key Financials
      38. Figure 15 SynCardia Systems, LLC.: Segmental Revenue
      39. Figure 16 SynCardia Systems, LLC: Geographical Revenue
      40. Figure 17 BiVACOR Inc.: Key Financials
      41. Figure 18 BiVACOR Inc.: Segmental Revenue
      42. Figure 19 BiVACOR Inc.: Geographical Revenue
      43. Figure 20 CARMAT: Key Financials
      44. Figure 21 CARMAT: Segmental Revenue
      45. Figure 22 CARMAT: Geographical Revenue
      46. Figure 23 ABIOMED: Key Financials
      47. Figure 24 ABIOMED: Segmental Revenue
      48. Figure 25 ABIOMED.: Geographical Revenue

    Artificial Heart Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials